LUMO   $3.89  -0.51% Market Open

Lumos Pharma Inc
Total Cash 16.80M
totalCashPerShare 2.068
EBITDA -37.59M
Total Debt 449.00K
quickRatio 3.438
currentRatio 4.233
Total Revenue 1.49M
debtToEquity 4.37
Revenue/Share 0.184
ROA -0.60501
ROE -1.32561
grossProfits
freeCashflow -22.13M
operatingCashflow -34.49M
earningsGrowth
revenueGrowth -0.074
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -16.030739
profitMargins 0.0
enterpriseValue 15.58M
forwardPE -1.7853881
floatShares 5.32M
sharesOutstanding 8.12M
sharesShort 308.33K
sharesShortPriorMonth 449.32K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.35%
heldPercentInstitutions 0.26%
Short Ratio help_outline 2.31%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 1.265
Price To Book help_outline 3.09
earningsQuarterlyGrowth
netIncomeToCommon -35.75M
trailingEps -4.42%
forwardEps -2.19%
enterpriseToEbitda -0.41
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.69 3Q 2024
institutionsCount 41
lastUpdated Sept. 16, 2024, 7:51 p.m.